BofA’s Hartnett says concentrated U.S. stock returns are likely to persist
Investing.com - Revance The (NASDAQ: RVNC) reported second quarter EPS of $-0.360, in line with the analyst estimate of $-0.360. Revenue for the quarter came in at $65.3M versus the consensus estimate of $66.3M.
Guidance
Revance The sees FY 2024 revenue of $280.000M versus the analyst consensus of $278.100M.
Revance The's stock price closed at $2.95. It is down -11.140% in the last 3 months and down -85.410% in the last 12 months.
Revance The saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Revance The's stock price’s past reactions to earnings here.
According to InvestingPro, Revance The's Financial Health score is "fair performance".
Check out Revance The's recent earnings performance, and Revance The's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar